We have shown that VV-αFAP TCE only modestly increases survival of mice bearing tumours (Supplementary Figure 12E), compared to VV-αCEA TCE treatment, suggesting that VV may replicate and kill CAF populations in the TME effectively (35), even in the absence of TCE. Here, AFAP1 is linked to neoplasm.